Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies
Disease area: Airway diseases, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. Trofor, R. Miron, M. Ciobanu, E. Barnea, V. Esanu (Iasi, Romania). Efficacy and safety of varenicline in a smokers population with high prevalence of comorbidities. Eur Respir J 2010; 36: Suppl. 54, 2060

Member's Comments

No comment yet.

Related content which might interest you: Efficacy and safety of bupropion for the treatment of smoking cessation in patients with chronic bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 503s Year: 2004 The cost-effectiveness of antidepressants for smoking cessation in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 801s Year: 2006 Comparative effectiveness of add-on omalizumab for the treatment of severe persistent asthma between current and former smokers vs. non-smokers Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Behavioural intervention increased efficacy of bupropion in a group of mexican heavy smokers Source: Eur Respir J 2003; 22: Suppl. 45, 125s Year: 2003 Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases Source: Annual Congress 2008 - Smoking cessation and new tobacco uses Year: 2008 Evaluation of varenicline plus behavioural intervention in a group of Mexican smokers Source: Annual Congress 2008 - Smoking cessation and new tobacco uses Year: 2008 The effectiveness and safety of empirical anti-TB therapy in a population with high TB prevalence Source: Eur Respir J 2001; 18: Suppl. 33, 468s Year: 2001 Prevalence of COPD in heroin smokers attending treatment centres assessed using LLN and relationship to drug consumption Source: International Congress 2018 – COPD around the world Year: 2018 The use of electronic cigarette by smokers and ex-smokers is associated with a poor perceived health status in the population-based Constances cohort Source: International Congress 2018 – Innovative tobacco cessation approaches and trends in tobacco and e-cigarette use Year: 2018 Highest prevalence of respiratory symptoms among smokers who also use e-cigarettes Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes Year: 2017 Comparison of efficacy of varenicline and nortriptyline– Short-term smoking cessation in outpatient setting Source: International Congress 2016 – Emerging issues in smoking cessation and tobacco products Year: 2016 Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD Source: Annual Congress 2010 - Smoking related disorders and smoking cessation Year: 2010 Effectiveness of treatment with varenicline in smokers with cardiovascular diseases (CVD) Source: Annual Congress 2009 - Smoking cessation Year: 2009 Predictors of success in smoking cessation among Brazilian subjects Source: Annual Congress 2012 - Tobacco use and cessation Year: 2012 Effectiveness of smoking cessation in patients with psychiatric disease Source: Annual Congress 2012 - Tobacco comorbidity Year: 2012 Comaprison of COPD readmission rates in patients with and without a history of illicit drug smoking Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012 Comparison of efficacy of two smoking cessation methods among doctors-active smokers Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies Year: 2010 Efficacy of a smoking cessation program in anxious and depressed current smokers Source: Eur Respir J 2002; 20: Suppl. 38, 133s Year: 2002 Nicotine dependence and prevalence of the COPD symptoms among smokers Source: Annual Congress 2007 - Smoking and the lung Year: 2007 Use of varenicline in the treatment of smokers with cardiovascular disease Source: Annual Congress 2013 –Smoking cessation Year: 2013